Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study - Wikidata - awgldk - TriplyDB

Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study

Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study

http://www.wikidata.org/entity/Q33805921

about

The Use of Vedolizumab in Patients with Concomitant Cirrhosis and Crohn's Disease

P2860

Q57301067-FA798127-8134-44A7-8EAD-01E366E1DD5F

P2860

Drug-induced liver injury in inflammatory bowel disease: 1-year prospective observational study

http://www.wikidata.org/entity/Q33805921

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Drug-induced liver injury in i ...... rospective observational study

@ast

Drug-induced liver injury in i ...... rospective observational study

@en

type

label

Drug-induced liver injury in i ...... rospective observational study

@ast

Drug-induced liver injury in i ...... rospective observational study

@en

prefLabel

Drug-induced liver injury in i ...... rospective observational study

@ast

Drug-induced liver injury in i ...... rospective observational study

@en

P1433

Q33805921-86AE3372-92B2-402A-A8BF-3B1580212DA5

P1476

Q33805921-005E9DB5-2508-4E97-8DEE-A1F04A58FB76

P2093

Q33805921-237412E5-D378-48F6-8C96-24FD36D8337A

Q33805921-2A359FC4-1E6D-45B9-B21F-B772B4F02599

Q33805921-34C7284A-858B-4B5B-AA97-08E9900B4C42

Q33805921-3DB4FC5C-2CE5-4606-A444-78271FBF729F

Q33805921-6BBBEF12-C95E-43F6-BA92-EE2A43CD4FF4

Q33805921-B2AF61BE-1BBD-4B96-946D-FF24594699C8

Q33805921-E945FF6D-3258-4B57-9977-5E278737AD8C

Q33805921-F764C122-DBC0-40E4-98D7-A185E2663F84

P2860

Q33805921-0729875F-DEC1-4D1B-96D4-F83269DB410C

Q33805921-0EC1F97B-F166-4CB3-84F0-5FBCDF022DC0

Q33805921-146E8C29-B094-4C91-A463-12E27D283613

Q33805921-180FA5C8-1721-4F56-A720-4B64ED28F34B

Q33805921-1EFA58F1-31FF-4148-A7BE-4D8630BCD5FA

Q33805921-2058F363-FB25-4B23-BAD7-7DA717C46609

Q33805921-37DB0A27-9F4C-4973-BB3A-4145540F9D88

Q33805921-3B40E8B6-0E09-42FD-86D4-673C2F02166C

Q33805921-4979BEE1-0D80-405E-8073-359AF8B55337

Q33805921-5C538E9B-5AEF-4EE8-86B2-776A65749E11

P304

Q33805921-542D00C7-D44B-47DF-AB2C-AAF38B590429

P31

Q33805921-322871A7-5799-4E50-A3C8-306ACB344033

P356

Q33805921-16727D78-BDCA-4B24-81C9-156274C3632D

P407

Q33805921-29CEABC2-F765-452F-9868-48B600C6E665

P433

Q33805921-12193BE8-97A9-4D5B-AA1D-36803D58279B

P478

Q33805921-7E88017F-3B6D-413F-9445-9137F6D2137D

P577

Q33805921-5C50B69D-FBAA-4104-A922-3FEA3AEA68BE

P698

Q33805921-FFAA0EF8-E176-481B-8D0B-24A93A40465C

P932

Q33805921-889275C3-4587-426D-B379-9498322B0D71

P356

WJG.V23.I22.4102

P1433

World Journal of Gastroenterology

P1476

Drug-induced liver injury in i ...... rospective observational study

@en

P2093

Anna Krajcovicova

http://www.w3.org/2001/XMLSchema#string

Jozef Toth

http://www.w3.org/2001/XMLSchema#string

Juraj Payer

http://www.w3.org/2001/XMLSchema#string

Martina Galambosova

http://www.w3.org/2001/XMLSchema#string

Michaela Kubincova

http://www.w3.org/2001/XMLSchema#string

Simona Filakovska

http://www.w3.org/2001/XMLSchema#string

Tibor Hlavaty

http://www.w3.org/2001/XMLSchema#string

Tomas Koller

http://www.w3.org/2001/XMLSchema#string

P2860

Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine

Chronic liver injury induced by drugs: a systematic review.

Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy.

Evaluation of drug-induced serious hepatotoxicity (eDISH): application of this data organization approach to phase III clinical trials of rivaroxaban after total hip or knee replacement surgery.

Azathioprine and 6-Mercaptopurine-induced Liver Injury: Clinical Features and Outcomes

Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention.

Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver Agreement.

Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review.

Utility of the Roussel Uclaf Causality Assessment Method (RUCAM) to analyze the hepatic findings in a clinical trial program: evaluation of the direct thrombin inhibitor ximelagatran.

A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease.

P304

4102-4111

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V23.I22.4102

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28652663

http://www.w3.org/2001/XMLSchema#string

P932

5473129

http://www.w3.org/2001/XMLSchema#string